Result Page 2 for Country: Germany Exchange: Frankfurt Sector: Healthcare Industry: Biotechnology Stock Market - Quotes & Prices
List of all Stocks and Equities with Prices, Market Capitalizations, PE and EPS
Germany (648)
- {{country.name}}
- All countries
- Germany (648)
Frankfurt (648)
Healthcare (648)
- {{item.name}}
- All sectors
- Healthcare (648)
Biotechnology (648)
- {{item.name}}
- All Industries
- Biotechnology (648)
- Drug Manufacturers-General (45)
- Drug Manufacturers-Specialty & Generic (276)
- Healthcare Plans (9)
- Medical Care Facilities (93)
- Pharmaceutical Retailers (21)
- Health Information Services (81)
- Medical Devices (201)
- Medical Instruments & Supplies (106)
- Diagnostics & Research (101)
- Medical Distribution (22)
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
M.Cap Market Cap | VOL Volume | 24h low | 24h high | Market Cap | P/E Ratio | EPS |
|---|
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
M.Cap Market Cap | VOL Volume | 24h low | 24h high | Market Cap | P/E Ratio | EPS | |
|---|---|---|---|---|---|---|---|---|---|---|
| {{ item.name }} {{ item.symbol }} | {{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.marketcap }} {{ item.marketcap_usd }} | {{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.marketcap }} {{ item.marketcap_usd }} | {{ item.pe }} | {{ item.eps }} {{ item.eps_usd }} | |
| Galapagos NV GXE.F | $28.78 31.46 USD |
+0.56
|
$1.9B 2.07B USD | $251 274.38 USD | $28.68 31.35 USD | $29 31.7 USD | $1.9B 2.07B USD | 0 | -$0.06 -0.06 USD | |
| Galapagos NV GXEA.F | $27.6 30.17 USD |
0
|
$1.88B 2.05B USD | $150 163.97 USD | $27.6 30.17 USD | $27.6 30.17 USD | $1.88B 2.05B USD | 0 | -$0.06 -0.06 USD | |
| Shanghai Haohai Biological Technology Co., Ltd. 5HB.F | $4.56 4.98 USD |
-2.15
|
$1.83B 2B USD | $682 745.52 USD | $4.56 4.98 USD | $4.56 4.98 USD | $1.83B 2B USD | 14.70 | $0.31 0.34 USD | |
| Syndax Pharmaceuticals, Inc. 1T3.F | $20.4 22.3 USD |
+2
|
$1.73B 1.9B USD | $100 109.31 USD | $20.4 22.3 USD | $20.4 22.3 USD | $1.73B 1.9B USD | 0 | -$2.78 -3.03 USD | |
| 3SBio Inc. 83B.F | $0.6899 0.75 USD |
+0.74
|
$1.73B 1.89B USD | $1K 1.09K USD | $0.6899 0.75 USD | $0.6899 0.75 USD | $1.73B 1.89B USD | 8.56 | $0.08 0.09 USD | |
| Catalyst Pharmaceuticals, Inc. CN2.F | $14.56 15.92 USD |
0
|
$1.72B 1.88B USD | $350 382.6 USD | $14.56 15.92 USD | $14.56 15.92 USD | $1.72B 1.88B USD | 24.67 | $0.59 0.64 USD | |
| BioArctic AB (publ) B9A.F | $17.94 19.61 USD |
+1.76
|
$1.64B 1.79B USD | $30 32.79 USD | $17.82 19.48 USD | $17.94 19.61 USD | $1.64B 1.79B USD | 71.76 | $0.25 0.27 USD | |
| Agios Pharmaceuticals, Inc. 8AP.F | $28.6 31.26 USD |
+2.88
|
$1.61B 1.76B USD | $200 218.63 USD | $28.6 31.26 USD | $28.6 31.26 USD | $1.61B 1.76B USD | 0 | -$5.9 -6.4 USD | |
| Bavarian Nordic A/S BV3.F | $20.48 22.39 USD |
+1.24
|
$1.6B 1.74B USD | $53 57.94 USD | $20.25 22.14 USD | $20.48 22.39 USD | $1.6B 1.74B USD | 7.96 | $2.57 2.81 USD | |
| Ardelyx, Inc. 41X.F | $6.8 7.43 USD |
+3.79
|
$1.58B 1.73B USD | $300 327.94 USD | $6.8 7.43 USD | $6.8 7.43 USD | $1.58B 1.73B USD | 0 | -$0.28 -0.3 USD | |
| Veracyte, Inc. 12V.F | $19.2 20.99 USD |
+0.52
|
$1.44B 1.58B USD | $50 54.66 USD | $19.2 20.99 USD | $19.2 20.99 USD | $1.44B 1.58B USD | 0 | -$0.95 -1.03 USD | |
| Kura Oncology, Inc. KUR.F | $18.88 20.64 USD |
+2.97
|
$1.44B 1.57B USD | $50 54.66 USD | $18.88 20.64 USD | $18.88 20.64 USD | $1.44B 1.57B USD | 0 | -$1.94 -2.1 USD | |
| Akero Therapeutics, Inc. 0K4.F | $20.31 22.2 USD |
+0.15
|
$1.43B 1.56B USD | $10 10.93 USD | $20.31 22.2 USD | $20.31 22.2 USD | $1.43B 1.56B USD | 0 | -$2.7 -2.9 USD | |
| Morphic Holding, Inc. 31Y.F | $28.2 30.83 USD |
+2.17
|
$1.41B 1.54B USD | $228 249.23 USD | $27.8 30.39 USD | $28.2 30.83 USD | $1.41B 1.54B USD | 0 | -$3.35 -3.6 USD | |
| Biotest Aktiengesellschaft BIO.F | $41.4 45.26 USD |
-1.9
|
$1.4B 1.53B USD | $100 109.31 USD | $41.4 45.26 USD | $41.4 45.26 USD | $1.4B 1.53B USD | 12.93 | $3.2 3.5 USD | |
| Biotest Aktiengesellschaft BIO3.F | $28.5 31.15 USD |
0
|
$1.4B 1.53B USD | $480 524.7 USD | $28.5 31.15 USD | $28.5 31.15 USD | $1.4B 1.53B USD | 8.90 | $3.2 3.5 USD | |
| Genus plc GBE.F | $20.8 22.74 USD |
+4.52
|
$1.38B 1.5B USD | $43 47 USD | $20.8 22.74 USD | $20.8 22.74 USD | $1.38B 1.5B USD | 35.25 | $0.59 0.64 USD | |
| Zai Lab Limited 1ZL.F | $13.7 14.98 USD |
-2.14
|
$1.36B 1.49B USD | $50 54.66 USD | $13.7 14.98 USD | $13.7 14.98 USD | $1.36B 1.49B USD | 0 | -$3.26 -3.5 USD | |
| Ligand Pharmaceuticals Incorporated LGDN.F | $76 83.08 USD |
+1.33
|
$1.35B 1.47B USD | $1 1.09 USD | $76 83.08 USD | $76 83.08 USD | $1.35B 1.47B USD | 26.85 | $2.83 3.09 USD | |
| Autolus Therapeutics plc 6A3A.F | $4.7 5.14 USD |
-0.84
|
$1.25B 1.37B USD | $360 393.53 USD | $4.7 5.14 USD | $4.7 5.14 USD | $1.25B 1.37B USD | 0 | -$1.12 -1.2 USD | |
| Verona Pharma plc I9SA.F | $14.9 16.29 USD |
0
|
$1.21B 1.32B USD | $120 131.18 USD | $14.7 16.07 USD | $14.9 16.29 USD | $1.21B 1.32B USD | 0 | -$0.67 -0.7 USD | |
| AbCellera Biologics Inc. 8QQ.F | $4.04 4.42 USD |
-2.3
|
$1.18B 1.29B USD | $231 252.51 USD | $4.04 4.42 USD | $4.06 4.44 USD | $1.18B 1.29B USD | 0 | -$0.48 -0.5 USD | |
| Xencor, Inc. XE9.F | $18.8 20.55 USD |
+1.62
|
$1.17B 1.28B USD | $300 327.94 USD | $18.8 20.55 USD | $18.9 20.66 USD | $1.17B 1.28B USD | 0 | -$1.94 -2.1 USD | |
| Prothena Corporation plc 0PT.F | $21.6 23.61 USD |
0
|
$1.16B 1.27B USD | $30 32.79 USD | $21.6 23.61 USD | $21.6 23.61 USD | $1.16B 1.27B USD | 0 | -$2.57 -2.8 USD | |
| Oxford Nanopore Technologies plc 4R0.F | $1.35 1.47 USD |
+2.12
|
$1.16B 1.27B USD | $400 437.25 USD | $1.35 1.47 USD | $1.35 1.47 USD | $1.16B 1.27B USD | 0 | -$0.18 -0.1 USD | |
| Ocular Therapeutix, Inc. 0OT.F | $7.62 8.33 USD |
+5.04
|
$1.13B 1.24B USD | $150 163.97 USD | $7.62 8.33 USD | $7.64 8.35 USD | $1.13B 1.24B USD | 0 | -$0.95 -1.03 USD | |
| Mirum Pharmaceuticals, Inc. 08D.F | $23.8 26.02 USD |
+0.85
|
$1.12B 1.22B USD | $25 27.33 USD | $23.8 26.02 USD | $24 26.24 USD | $1.12B 1.22B USD | 0 | -$3.73 -4.07 USD | |
| Pharvaris N.V. 9EN.F | $20 21.86 USD |
-0.99
|
$1.1B 1.2B USD | $60 65.59 USD | $20 21.86 USD | $20.6 22.52 USD | $1.1B 1.2B USD | 0 | -$2.63 -2.8 USD | |
| Liquidia Corporation LT4.F | $14.18 15.5 USD |
+3.73
|
$1.08B 1.18B USD | $2.1K 2.29K USD | $14.18 15.5 USD | $14.18 15.5 USD | $1.08B 1.18B USD | 0 | -$1.13 -1.2 USD | |
| Centessa Pharmaceuticals plc 260.F | $10.7 11.7 USD |
+7.54
|
$1.07B 1.17B USD | $45 49.19 USD | $10.6 11.59 USD | $10.7 11.7 USD | $1.07B 1.17B USD | 0 | -$1.46 -1.5 USD | |
| MannKind Corporation NNFN.F | $3.96 4.33 USD |
+1.72
|
$1.07B 1.17B USD | $100 109.31 USD | $3.96 4.33 USD | $3.96 4.33 USD | $1.07B 1.17B USD | 0 | -$0.04 -0.04 USD | |
| MacroGenics, Inc. M55.F | $17.09 18.68 USD |
+1.91
|
$1.07B 1.17B USD | $175 191.3 USD | $17.09 18.68 USD | $17.09 18.68 USD | $1.07B 1.17B USD | 0 | -$0.14 -0.1 USD | |
| Cassava Sciences, Inc. PX91.F | $24.3 26.56 USD |
+6.02
|
$1.05B 1.15B USD | $207 226.28 USD | $24.3 26.56 USD | $24.3 26.56 USD | $1.05B 1.15B USD | 0 | -$2.16 -2.3 USD | |
| EyePoint Pharmaceuticals, Inc. PV3B.F | $20.88 22.82 USD |
+4.79
|
$1.04B 1.14B USD | $120 131.18 USD | $20.88 22.82 USD | $21.13 23.1 USD | $1.04B 1.14B USD | 0 | -$1.7 -1.8 USD | |
| Immatics N.V. 4A3.F | $10.01 10.94 USD |
+0.5
|
$1.03B 1.13B USD | $2.35K 2.57K USD | $10.01 10.94 USD | $10.01 10.94 USD | $1.03B 1.13B USD | 0 | -$1.2 -1.3 USD | |
| Silence Therapeutics plc XRP2.F | $20 21.86 USD |
+6.95
|
$1.03B 1.12B USD | $60 65.59 USD | $19.9 21.75 USD | $20 21.86 USD | $1.03B 1.12B USD | 0 | -$1.37 -1.4 USD | |
| Scholar Rock Holding Corporation 2QK.F | $13 14.21 USD |
+1.56
|
$1.01B 1.11B USD | $100 109.31 USD | $13 14.21 USD | $13 14.21 USD | $1.01B 1.11B USD | 0 | -$1.86 -2.03 USD | |
| Everest Medicines Limited 6HN.F | $3 3.28 USD |
+2.74
|
$993.33M 1.09B USD | $220 240.49 USD | $3 3.28 USD | $3 3.28 USD | $993.33M 1.09B USD | 0 | -$0.35 -0.3 USD | |
| BioCryst Pharmaceuticals, Inc. BO1.F | $4.78 5.23 USD |
+6.69
|
$986.22M 1.08B USD | $2K 2.19K USD | $4.69 5.12 USD | $4.78 5.23 USD | $986.22M 1.08B USD | 0 | -$1.1 -1.2 USD | |
| Viridian Therapeutics, Inc. 1S1.F | $14.9 16.29 USD |
+0.68
|
$935.24M 1.02B USD | $446 487.54 USD | $14.9 16.29 USD | $14.9 16.29 USD | $935.24M 1.02B USD | 0 | -$4.95 -5.4 USD | |
| Sage Therapeutics, Inc. SG7.F | $15.19 16.6 USD |
+0.16
|
$913.02M 998.06M USD | $600 655.88 USD | $15.19 16.6 USD | $15.33 16.75 USD | $913.02M 998.06M USD | 0 | -$8.44 -9.2 USD | |
| ABIVAX Société Anonyme 2X1.F | $13.78 15.06 USD |
-5.62
|
$867.01M 947.75M USD | $182 198.95 USD | $13.78 15.06 USD | $14.2 15.52 USD | $867.01M 947.75M USD | 0 | -$3.43 -3.7 USD | |
| Innoviva, Inc. HVE.F | $13.7 14.98 USD |
+0.74
|
$866.21M 946.89M USD | $60 65.59 USD | $13.7 14.98 USD | $13.7 14.98 USD | $866.21M 946.89M USD | 6.68 | $2.05 2.24 USD | |
| REGENXBIO Inc. RB0.F | $17.6 19.24 USD |
+1.15
|
$863.15M 943.54M USD | $15 16.4 USD | $17.6 19.24 USD | $17.6 19.24 USD | $863.15M 943.54M USD | 0 | -$5.61 -6.1 USD | |
| Nxera Pharma Co., Ltd. JSS.F | $9.45 10.33 USD |
+2.16
|
$845.27M 923.99M USD | $19 20.77 USD | $8.95 9.78 USD | $9.45 10.33 USD | $845.27M 923.99M USD | 0 | -$0.53 -0.5 USD | |
| GNI Group Ltd. 3G6.F | $16.2 17.71 USD |
-4.71
|
$829.23M 906.46M USD | $20 21.86 USD | $16.2 17.71 USD | $16.2 17.71 USD | $829.23M 906.46M USD | 16.03 | $1.01 1.1 USD | |
| Formycon AG FYB.F | $46.3 50.61 USD |
+0.87
|
$820.16M 896.55M USD | $75 81.99 USD | $46.3 50.61 USD | $46.3 50.61 USD | $820.16M 896.55M USD | 0 | -$3.78 -4.1 USD | |
| Ergomed plc 2EM.F | $14.68 16.05 USD |
0
|
$788.59M 862.04M USD | $0 0 USD | $0 0 USD | $0 0 USD | $788.59M 862.04M USD | 0 | $0 0 USD | |
| Bicycle Therapeutics plc 50BA.F | $20 21.86 USD |
-2.91
|
$787.53M 860.87M USD | $500 546.57 USD | $20 21.86 USD | $20 21.86 USD | $787.53M 860.87M USD | 0 | -$4.74 -5.1 USD | |
| Intercept Pharmaceuticals, Inc. I4P.F | $17.52 19.15 USD |
0
|
$738.99M 807.82M USD | $0 0 USD | $0 0 USD | $0 0 USD | $738.99M 807.82M USD | 0 | $0 0 USD | |
| Takara Bio Inc. TF2.F | $5.6 6.12 USD |
+0.9
|
$708.58M 774.57M USD | $277 302.8 USD | $5.6 6.12 USD | $5.6 6.12 USD | $708.58M 774.57M USD | 70.00 | $0.08 0.09 USD | |
| Aurinia Pharmaceuticals Inc. IKAP.F | $4.62 5.04 USD |
-0.24
|
$687.6M 751.64M USD | $100 109.31 USD | $4.62 5.04 USD | $4.62 5.04 USD | $687.6M 751.64M USD | 0 | -$0.5 -0.5 USD | |
| Savara Inc. YB4P.F | $4.96 5.42 USD |
+0.81
|
$685.21M 749.03M USD | $1.5K 1.64K USD | $4.96 5.42 USD | $4.96 5.42 USD | $685.21M 749.03M USD | 0 | -$0.31 -0.3 USD | |
| Pharming Group N.V. PHGN.F | $0.9899 1.08 USD |
+0.05
|
$680.17M 743.52M USD | $700 765.19 USD | $0.9899 1.08 USD | $0.9899 1.08 USD | $680.17M 743.52M USD | 0 | -$0.01 -0.01 USD | |
| Pharming Group N.V. PHG.F | $9.9 10.82 USD |
+2.06
|
$680.17M 743.52M USD | $41 44.82 USD | $9.75 10.66 USD | $10.1 11.04 USD | $680.17M 743.52M USD | 0 | -$0.15 -0.1 USD | |
| PureTech Health plc 0VQ0.F | $24.6 26.89 USD |
+1.65
|
$677.71M 740.83M USD | $39 42.63 USD | $24.6 26.89 USD | $24.6 26.89 USD | $677.71M 740.83M USD | 0 | -$1.58 -1.7 USD | |
| Wave Life Sciences Ltd. 1U5.F | $5.5 6.01 USD |
-1.79
|
$672.56M 735.2M USD | $400 437.25 USD | $5.5 6.01 USD | $5.6 6.12 USD | $672.56M 735.2M USD | 0 | -$0.5 -0.5 USD | |
| Stoke Therapeutics, Inc. 0GT.F | $12.4 13.55 USD |
+5.98
|
$643.06M 702.95M USD | $100 109.31 USD | $12.4 13.55 USD | $12.4 13.55 USD | $643.06M 702.95M USD | 0 | -$2.22 -2.4 USD | |
| Mind Medicine (MindMed) Inc. MMQ.F | $9.11 9.96 USD |
-4.61
|
$642.26M 702.08M USD | $1.41K 1.54K USD | $9.11 9.96 USD | $9.74 10.64 USD | $642.26M 702.08M USD | 0 | -$2.27 -2.4 USD | |
| Fate Therapeutics, Inc. F6T.F | $5.52 6.04 USD |
-2.16
|
$628.54M 687.08M USD | $625 683.21 USD | $5.52 6.04 USD | $5.52 6.04 USD | $628.54M 687.08M USD | 0 | -$1.53 -1.6 USD | |
| ORIC Pharmaceuticals, Inc. 4TZ.F | $9.2 10.06 USD |
-1.6
|
$619.86M 677.59M USD | $900 983.82 USD | $9.2 10.06 USD | $9.25 10.11 USD | $619.86M 677.59M USD | 0 | -$1.83 -2.0004 USD | |
| Ascentage Pharma Group International 36X.F | $2.04 2.23 USD |
-1.92
|
$614.33M 671.54M USD | $1.76K 1.92K USD | $2.04 2.23 USD | $2.14 2.34 USD | $614.33M 671.54M USD | 0 | -$0.42 -0.4 USD | |
| AnaptysBio, Inc. AN6.F | $21.2 23.17 USD |
+3.92
|
$567.38M 620.22M USD | $500 546.57 USD | $21.2 23.17 USD | $23 25.14 USD | $567.38M 620.22M USD | 0 | -$5.67 -6.1 USD | |
| Exscientia plc 0RK.F | $4.46 4.88 USD |
+3.24
|
$562.5M 614.88M USD | $2.71K 2.96K USD | $4.36 4.77 USD | $4.46 4.88 USD | $562.5M 614.88M USD | 0 | -$1.38 -1.5 USD | |
| Valneva SE AYJ0.F | $7.6 8.31 USD |
+2.01
|
$558.84M 610.88M USD | $1.26K 1.38K USD | $7.6 8.31 USD | $7.6 8.31 USD | $558.84M 610.88M USD | 0 | -$1.46 -1.5 USD | |
| Altimmune, Inc. 3G0.F | $7.74 8.46 USD |
+4.29
|
$548.52M 599.6M USD | $185 202.23 USD | $7.72 8.44 USD | $7.74 8.46 USD | $548.52M 599.6M USD | 0 | -$1.55 -1.6 USD | |
| GH Research PLC 1KA.F | $10.2 11.15 USD |
0
|
$542.77M 593.32M USD | $500 546.57 USD | $10.2 11.15 USD | $10.2 11.15 USD | $542.77M 593.32M USD | 0 | -$0.63 -0.6 USD | |
| Applied Therapeutics, Inc. 2UV.F | $4.92 5.37 USD |
-2.27
|
$520.54M 569.02M USD | $60 65.59 USD | $4.91 5.37 USD | $4.92 5.37 USD | $520.54M 569.02M USD | 0 | -$1.32 -1.4 USD | |
| IGM Biosciences, Inc. 1K0.F | $7.75 8.47 USD |
+4.03
|
$502.02M 548.77M USD | $12 13.12 USD | $7.75 8.47 USD | $7.75 8.47 USD | $502.02M 548.77M USD | 0 | -$4.39 -4.7 USD | |
| Arbutus Biopharma Corporation I9DN.F | $2.77 3.02 USD |
+2.14
|
$498.36M 544.78M USD | $800 874.51 USD | $2.77 3.02 USD | $2.77 3.02 USD | $498.36M 544.78M USD | 0 | -$0.41 -0.4 USD | |
| Ocumension Therapeutics 5DG.F | $0.6899 0.75 USD |
+1.48
|
$485.97M 531.23M USD | $109 119.15 USD | $0.68 0.74 USD | $0.6899 0.75 USD | $485.97M 531.23M USD | 0 | -$0.08 -0.08 USD | |
| Pharma Mar, S.A. PMRA.F | $27.6 30.17 USD |
0
|
$485.32M 530.52M USD | $99 108.22 USD | $27.6 30.17 USD | $27.6 30.17 USD | $485.32M 530.52M USD | 460.00 | $0.06 0.07 USD | |
| Calliditas Therapeutics AB (publ) LC8.F | $9.02 9.86 USD |
-5.3
|
$484.12M 529.21M USD | $352 384.78 USD | $9.02 9.86 USD | $9.35 10.22 USD | $484.12M 529.21M USD | 0 | -$0.75 -0.8 USD | |
| UroGen Pharma Ltd. UR8.F | $11.5 12.57 USD |
-2.54
|
$481.62M 526.48M USD | $580 634.02 USD | $11.5 12.57 USD | $12.1 13.23 USD | $481.62M 526.48M USD | 0 | -$3.31 -3.6 USD | |
| Calliditas Therapeutics AB (publ) LC8A.F | $17.3 18.91 USD |
-8.95
|
$480.71M 525.48M USD | $98 107.13 USD | $17.3 18.91 USD | $18.9 20.66 USD | $480.71M 525.48M USD | 0 | -$1.51 -1.6 USD | |
| Editas Medicine, Inc. 8EM.F | $5.83 6.37 USD |
-6.54
|
$476.97M 521.4M USD | $130 142.11 USD | $5.83 6.37 USD | $6.08 6.65 USD | $476.97M 521.4M USD | 0 | -$1.88 -2.05 USD | |
| KalVista Pharmaceuticals, Inc. 4XC1.F | $11.2 12.24 USD |
+2.75
|
$472.51M 516.52M USD | $135 147.57 USD | $11.1 12.13 USD | $11.2 12.24 USD | $472.51M 516.52M USD | 0 | -$2.91 -3.1 USD | |
| Clinuvel Pharmaceuticals Limited UR9.F | $9.27 10.13 USD |
+0.27
|
$464.43M 507.68M USD | $120 131.18 USD | $9.16 10.01 USD | $9.27 10.13 USD | $464.43M 507.68M USD | 26.47 | $0.35 0.38 USD | |
| Clinuvel Pharmaceuticals Limited UR9A.F | $8.95 9.78 USD |
-1.1
|
$461.5M 504.48M USD | $24 26.24 USD | $8.95 9.78 USD | $8.95 9.78 USD | $461.5M 504.48M USD | 25.57 | $0.35 0.38 USD | |
| Theravance Biopharma, Inc. 0TB.F | $8.3 9.07 USD |
-6.21
|
$435.06M 475.58M USD | $150 163.97 USD | $8.3 9.07 USD | $8.3 9.07 USD | $435.06M 475.58M USD | 0 | -$0.93 -1.01 USD | |
| Voyager Therapeutics, Inc. VT6.F | $8 8.75 USD |
-1.36
|
$434.4M 474.86M USD | $185 202.23 USD | $8 8.75 USD | $8.17 8.93 USD | $434.4M 474.86M USD | 2.88 | $2.77 3.03 USD | |
| Mersana Therapeutics, Inc. 0M4.F | $3.38 3.7 USD |
-0.97
|
$429.73M 469.76M USD | $60 65.59 USD | $3.38 3.7 USD | $3.38 3.7 USD | $429.73M 469.76M USD | 0 | -$1.38 -1.5 USD | |
| Larimar Therapeutics, Inc. ZA71.F | $6.6 7.21 USD |
+5.6
|
$421.08M 460.3M USD | $54 59.03 USD | $6.6 7.21 USD | $6.6 7.21 USD | $421.08M 460.3M USD | 0 | -$0.78 -0.8 USD | |
| Heron Therapeutics, Inc. AXD2.F | $2.8 3.06 USD |
+11.82
|
$420.92M 460.12M USD | $500 546.57 USD | $2.69 2.94 USD | $2.8 3.06 USD | $420.92M 460.12M USD | 0 | -$0.75 -0.8 USD | |
| Revance Therapeutics, Inc. RTI.F | $4.02 4.39 USD |
+2.03
|
$418.95M 457.97M USD | $1.5K 1.64K USD | $4.02 4.39 USD | $4.04 4.42 USD | $418.95M 457.97M USD | 0 | -$3.57 -3.9 USD | |
| CK Life Sciences Int'l., (Holdings) Inc. LSI.F | $0.04 0.04 USD |
-1.27
|
$417.26M 456.13M USD | $3K 3.28K USD | $0.04 0.04 USD | $0.04 0.04 USD | $417.26M 456.13M USD | 0 | $0 0 USD | |
| Replimune Group, Inc. 7R8.F | $6.6 7.21 USD |
+3.94
|
$408.63M 446.68M USD | $28 30.61 USD | $6.6 7.21 USD | $6.65 7.27 USD | $408.63M 446.68M USD | 0 | -$2.95 -3.2 USD | |
| Adaptive Biotechnologies Corporation 1HM.F | $2.5 2.73 USD |
-1.34
|
$407.15M 445.07M USD | $172 188.02 USD | $2.41 2.63 USD | $2.5 2.73 USD | $407.15M 445.07M USD | 0 | -$1.45 -1.5 USD | |
| Marinus Pharmaceuticals, Inc. 61Y.F | $7.3 7.98 USD |
-1.35
|
$401M 438.34M USD | $800 874.51 USD | $7.3 7.98 USD | $7.3 7.98 USD | $401M 438.34M USD | 0 | -$2.45 -2.6 USD | |
| Atai Life Sciences N.V. 9VC.F | $2.29 2.5 USD |
-0.3
|
$380.2M 415.61M USD | $29.2K 31.92K USD | $2.29 2.5 USD | $2.29 2.5 USD | $380.2M 415.61M USD | 0 | -$0.23 -0.2 USD | |
| Mereo BioPharma Group plc MAH0.F | $2.5 2.73 USD |
-5.3
|
$355.66M 388.79M USD | $930 1.02K USD | $2.5 2.73 USD | $2.5 2.73 USD | $355.66M 388.79M USD | 0 | -$0.19 -0.2 USD | |
| Hyloris Pharmaceuticals SA 52U.F | $12.2 13.34 USD |
+0.83
|
$341.6M 373.42M USD | $162 177.09 USD | $12.2 13.34 USD | $12.2 13.34 USD | $341.6M 373.42M USD | 0 | -$0.56 -0.6 USD | |
| MeiraGTx Holdings plc 328.F | $5.3 5.79 USD |
+2.91
|
$340.35M 372.05M USD | $13.26K 14.49K USD | $5.25 5.74 USD | $5.3 5.79 USD | $340.35M 372.05M USD | 0 | -$1.39 -1.5 USD | |
| Precigen, Inc. I5X.F | $1.34 1.46 USD |
+0.22
|
$333.3M 364.34M USD | $500 546.57 USD | $1.34 1.46 USD | $1.34 1.46 USD | $333.3M 364.34M USD | 0 | -$0.36 -0.3 USD | |
| Anavex Life Sciences Corp. 12X1.F | $3.99 4.36 USD |
+2.97
|
$328.79M 359.41M USD | $400 437.25 USD | $3.99 4.36 USD | $4.05 4.43 USD | $328.79M 359.41M USD | 0 | -$0.5 -0.5 USD | |
| Enanta Pharmaceuticals, Inc. 9EP.F | $15.1 16.51 USD |
-1.31
|
$324.45M 354.67M USD | $3 3.28 USD | $15.1 16.51 USD | $15.6 17.05 USD | $324.45M 354.67M USD | 0 | -$6.12 -6.6 USD | |
| Renovaro Inc. 2Q5.F | $2.25 2.46 USD |
-0.88
|
$323.25M 353.36M USD | $8K 8.75K USD | $2.25 2.46 USD | $2.26 2.47 USD | $323.25M 353.36M USD | 0 | -$0.65 -0.7 USD | |
| Sutro Biopharma, Inc. S09.F | $4.12 4.5 USD |
+5.64
|
$316.91M 346.43M USD | $2.15K 2.35K USD | $4.12 4.5 USD | $4.14 4.53 USD | $316.91M 346.43M USD | 0 | -$1.66 -1.8 USD | |
| Adaptimmune Therapeutics plc 473A.F | $1.24 1.36 USD |
+5.08
|
$316.9M 346.41M USD | $4K 4.37K USD | $1.17 1.28 USD | $1.24 1.36 USD | $316.9M 346.41M USD | 0 | -$0.5 -0.5 USD | |
| CorMedix Inc. 19KA.F | $5.7 6.23 USD |
+9.62
|
$313.39M 342.58M USD | $85 92.92 USD | $5.7 6.23 USD | $5.85 6.39 USD | $313.39M 342.58M USD | 0 | -$0.85 -0.9 USD | |
|
No favorite stocks
You do not have a favorite stocks yet, please add it to favorites to see it here |
||||||||||